Blood test to predict nerve damage from chemotherapy
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study looks at whether a simple blood test can predict if chemotherapy will cause nerve damage (tingling, numbness, or pain). It may help doctors adjust treatment early to reduce these side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are being treated for cancer.
- You will receive one of these chemotherapy drugs: paclitaxel, docetaxel, or oxaliplatin, for at least 9 weeks.
- You do not already have nerve pain or neuropathy (tingling, numbness, burning).
- You do not have type 1 diabetes or type 2 diabetes lasting more than 10 years.
- You have not had other nerve-damaging cancer treatments in the past.
- You are not receiving immunotherapy along with your chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
Hear when a new Chemotherapy Induced Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.